Preclinical pharmacokinetics of the novel PI3K inhibitor GDC-0941 and prediction of its pharmacokinetics and efficacy in human

By Salphati Laurent   Pang Jodie   Plise Emile G.   Chou Bilin   Halladay Jason S.   Olivero Alan G.   Rudewicz Patrick J.   Tian Qingping   Wong Susan   Zhang Xiaolin  

Xenobiotica, Vol. 41, Iss. 12, 2011-12 ,pp. : 1088-1099

Informa Healthcare

Access to resources Recommend Favorite

Preclinical pharmacokinetics of the radiomitigator KZ-41 in rats

By Zeng Kui   Thompson Karin Emmons   Presley Chaela S.   Miller Duane D.   Yates Charles R.  

Xenobiotica, Vol. 41, Iss. 11, 2011-11 ,pp. : 1006-1012

Informa Healthcare

Access to resources Recommend Favorite

The efficacy and safety of golimumab in the treatment of arthritis

By Fleischmann Roy  

Expert Opinion on Biological Therapy, Vol. 10, Iss. 7, 2010-07 ,pp. : 1131-1143

Informa Healthcare

Access to resources Recommend Favorite

Integrated analysis of safety and efficacy of a plasma- and albumin-free recombinant factor VIII (rAHF-PFM) from six clinical studies in patients with hemophilia A

By Shapiro Amy   Gruppo Ralph   Pabinger Ingrid   Collins Peter W   Hay Charles RM   Schroth Phillip   Casey Kathleen   Patrone Lisa   Ehrlich Hartmut   Ewenstein Bruce M  

Expert Opinion on Biological Therapy, Vol. 9, Iss. 3, 2009-03 ,pp. : 273-283

Informa Healthcare

Access to resources Recommend Favorite

Preclinical pharmacokinetics of SB-203580, a potent inhibitor of p38 mitogen-activated protein kinase

By Ward K. W.   Proksch J. W.   Azzarano L. M.   Mumaw J. A.   Roethke T. J.   Stelman G. J.   Walsh M. J.   Zeigler K. S.   McSurdy-Freed J. E.   Kehler J. R   Chokshi J.   Levy M. A.   Smith B. R.  

Xenobiotica, Vol. 31, Iss. 11, 2001-11 ,pp. : 783-797

Informa Healthcare

Access to resources Recommend Favorite